Der Schmerz
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ The clinical diagnosis of fibromyalgia syndrome can be established by the American College of Rheumatology (ACR) 1990 classification criteria (with examination of tender points) or without the examination of tender points by the modified preliminary diagnostic ACR 2010 or 2011 criteria.
-
Review Meta Analysis
[Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups].
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was planned for April 2017. ⋯ Fibromyalgia syndrome is most probably the end result of various pathogenetic factors and pathophysiological mechanisms.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ Amitriptyline and duloxetine are recommended in the case of comorbid depressive disorders or generalized anxiety disorder and pregabalin in the case of generalized anxiety disorder. Off-label use of duloxetine and pregabalin can be considered if there are no comorbid mental disorders or no generalized anxiety disorder. Strong opioids are not recommended.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ Low to moderate intensity endurance and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial magnetic stimulation are not recommended.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ Cognitive behavioral therapies received a strong recommendation but biofeedback, guided imagery and hypnosis received a weak recommendation.